Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NRD103JP trial of sodium hyaluronate in enthesopathy
jRCT2080221589Phase 3
- Sponsor
- Chugai Pharmaceutical Co., Ltd.
- Start
- Sep 2011
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in enthesiopathy comparing Sodium hyaluronate with Placebo (2 arms).
02
Drugs
sodium hyaluronate
03
Conditions
enthesiopathy
Beyond the preview
Go deeper on jRCT2080221589.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221589.